Author(s):
Rutuja Pawar, Avinash A. Gunjal, Harshal A. Vishe, Rupali V. Karale, Aditi D. Bangar
Email(s):
avinashgunjal4247@gmail.com
DOI:
10.52711/2231-5713.2026.00028 
Address:
Rutuja Pawar1, Avinash A. Gunjal2*, Harshal A. Vishe2, Rupali V. Karale3, Aditi D. Bangar3
1Research Scholar, Siddhi’s Institute of Pharmacy, Nandgaon, Murbad, Thane - 421401, Maharashtra, India.
2Assistant Professor, Siddhi’s Institute of Pharmacy, Nandgaon, Murbad, Thane - 421401, Maharashtra, India.
3Lecturer, Siddhi’s Institute of Pharmacy, Nandgaon, Murbad, Thane - 421401, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2026
ABSTRACT:
Experimental pharmacology plays a pivotal role in understanding drug actions, mechanisms, and safety profiles through laboratory-based investigations. Traditionally, it relied on in-vivo, in-vitro, and ex-vivo methods; however, these approaches often face limitations such as ethical concerns, lack of physiological relevance, and low predictive accuracy. Recent advancements have introduced innovative techniques that significantly enhance the precision, efficiency, and translational value of pharmacological studies. This review highlights cutting-edge methods such as in-silico modeling, high-throughput screening (HTS), 3D cell culture systems, and organ-on-a-chip technologies. In-silico techniques like molecular docking and QSAR modeling facilitate rapid prediction of drug-receptor interactions and biological activity, minimizing time and cost. HTS enables large-scale compound screening using automated platforms, accelerating early-stage drug discovery. 3D culture models and spheroid-based systems replicate the architectural and functional complexity of human tissues, offering improved insights into drug efficacy and resistance mechanisms. Additionally, organ-on-chip devices mimic organ-level physiology and allow real-time monitoring of drug effects, reducing dependence on animal models. These advancements not only address the limitations of conventional methods but also contribute to personalized medicine, toxicological screening, and disease modeling. The integration of these technologies into experimental pharmacology marks a transformative shift toward more predictive, ethical, and efficient drug development practices.
Cite this article:
Rutuja Pawar, Avinash A. Gunjal, Harshal A. Vishe, Rupali V. Karale, Aditi D. Bangar. Emerging Technologies in Experimental Pharmacology: A Comprehensive Review of Novel Screening and Modeling Techniques. Asian Journal of Pharmacy and Technology. 2026; 16(2):193-0. doi: 10.52711/2231-5713.2026.00028
Cite(Electronic):
Rutuja Pawar, Avinash A. Gunjal, Harshal A. Vishe, Rupali V. Karale, Aditi D. Bangar. Emerging Technologies in Experimental Pharmacology: A Comprehensive Review of Novel Screening and Modeling Techniques. Asian Journal of Pharmacy and Technology. 2026; 16(2):193-0. doi: 10.52711/2231-5713.2026.00028 Available on: https://ajptonline.com/AbstractView.aspx?PID=2026-16-2-13
REFERENCE:
1. Balagopalan D, Hussain G, Nidhin MM, Nambiar S, A review on experimental pharmacology, Journal of Drug Delivery and Therapeutics. 2019; 9(1-s): 501-504. DOI: http://dx.doi.org/10.22270/jddt.v9i1-s.2242.
2. Kashish R. Mulani, B.P. Chaudhari, V. K. Redasani, Kalyani Gardi. Drug Discovery and Development. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(2): 185-0.
3. Dibyajyoti Saha, Mayukh Jana, Supradip Mandal. Target Discovery and Validation: Advances in Molecular Pharmacology. Asian J. Pharm. Ana. 2011; 1(2): 27-28.
4. Shoaib Ahmad. Recent advances in Pharmacology and Toxicology of Phytopharmaceuticals. Asian J. Pharm. Res. 2017; 7(4): 222-224.
5. Chikhale H U. Review on In-silico techniques: An approach to Drug discovery. Current Trends in Pharmacy and Pharmaceutical Chemistry. 2020; 2(1): 24-32.
6. Shalini A. Shinde, Manasi J. Mhetar, Avantika G. Parit, Akash R. Thombre. In-silico Investigation and ADMET Prediction of Potential Antifungal Phytochemicals against Lanosterol 14-Alpha Demethylase Inhibitors. Asian Journal of Pharmaceutical Research. 2024; 14(1): 33-8.
7. Apeksha P. Motghare, Parimal P. Katolkar, Tina S. Lichade. In-Silico Prediction of Phytoconstituents from Phyllanthus niruri for Anticancer Activity against Prostate Cancer Targeting MRCK kinases. Research Journal of Pharmacy and Technology. 2023; 16(9): 4105-1.
8. Vishwajit S. Patil, Prithviraj A. Patil. Molecular Docking: A useful approach of Drug Discovery on the Basis of their Structure. Asian Journal of Pharmaceutical Research. 2023; 13(3): 191-5.
9. Nachiket S. Dighe, Pankaj Shinde, Harshali Anap, Sanjay Bhawar, Deepak S. Musmade. QSAR Study and Synthesis of some new 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives as Anti-microbial and Anti-inflammatory Agents. Asian J. Pharm. Res. 2014; 4(4): 174-179.
10. Sakshi Bhardwaj, Sonal Dubey. Qsar and Docking Studies of Some Novel Piperine Analogues as Monoamine Oxidase Inhibitors. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(2): 115-2.
11. Ravi Kumar. Drug Discovery (Lead Identification and High Throughput Screening). Research Journal of Pharmacology and Pharmacodynamics. 2021; 13(2): 46-0.
12. Suresh A. Marnoor. A Short Review on Organ-on-a-chip Technology. Asian Journal of Pharmacy and Technology. 2023; 13(2): 111-4.
13. Ajay I. Patel, Bhatt Isha, Amit J. Vyas, Nilesh Patel. Organ-on-a-chip and 3D printing as preclinical models for medical research and practice. International Journal of Technology. 2022; 12(1): 1-8.
14. Wu F, Zhou Y, Li L, et al. Computational Approaches in Preclinical Studies on Drug Discovery and Development. Front Chem. 2020; 8:726. doi:10.3389/fchem.2020.00726
15. Deng J, Yang Z, Ojima I, et al. Artificial Intelligence in Drug Discovery: Applications and Techniques. arXiv. 2021. Available from: https://arxiv.org/abs/2106.05386
16. Abhijit Ray. Scope of Embryonic Stem Cells in research. Asian J. Nur. Edu. and Research. 2012; 2(2): 51-54.
17. Gorgulla C. Recent Developments in Structure-Based Virtual Screening Approaches. arXiv. 2022. Available from: https://arxiv.org/abs/2211.03208
18. Hossain MK. Advancements in In-silico Toxicology Models for Drug Safety Assessment. World J Pharmacol Toxicol. 2024. Available from: https://www.omicsonline.org/open-access/advancements-in-insilico-toxicology-models-for-drug-safety-assessment-132396.html
19. Chu X, Wang Y, Tian P, et al. Advanced Sampling and Modeling in Molecular Simulations for Slow and Large-Scale Biomolecular Dynamics. Front Mol Biosci. 2021; 8:70. doi:10.3389/fmolb.2021.667157
20. Badar MS, Shamsi S, Ahmed J, Alam MA. Molecular dynamics simulations: Concept, Methods, and Applications. Springer. 2022.